CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration

British Journal of Cancer

Volumn 105, Issue 2, 2011, Pages 231-238

  Braig, S ^a   Wallner, S ^a   Junglas, B ^a   Fuchshofer, R ^a   Bosserhoff, A K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

CTGF; hypoxia; invasion; malignant melanoma; transcriptional regulation

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CONNECTIVE TISSUE GROWTH FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OSTEOGENIC PROTEIN 1; RECOMBINANT CONNECTIVE TISSUE GROWTH FACTOR; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL ADHESION; CELL ASSAY; CELL FUNCTION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EMBRYO; EXPRESSION VECTOR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOCYTE; MELANOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

BONE MORPHOGENETIC PROTEIN 7; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CONNECTIVE TISSUE GROWTH FACTOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; RNA, SMALL INTERFERING; SKIN NEOPLASMS; UP-REGULATION;

EID: 79960228013     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.226     Document Type: Article

References (38)

1. Babic AM, Chen CC, Lau LF (1999) Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogen-esis in vivo. Mol Cell Biol 19: 2958-2966 (Pubitemid 29144541)
2. Barcellos-Hoff MH, Akhurst RJ (2009) Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res 11: 202
3. Bellam N, Pasche B (2010) Tgf-beta signaling alterations and colon cancer. Cancer Treat Res 155: 85-103
4. Bradham DM, Igarashi A, Potter RL, Grotendorst GR (1991) Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114: 1285-1294 (Pubitemid 21909886)
5. Chen XM, Qi W, Pollock CA (2009) CTGF and chronic kidney fibrosis. Front Biosci (Schol Ed) 1: 132-141
6. Chu CY, Chang CC, Prakash E, Kuo ML (2008) Connective tissue growth factor (CTGF) and cancer progression. J Biomed Sci 15: 675-685
7. Cicha I, Goppelt-Struebe M (2009) Connective tissue growth factor: context-dependent functions and mechanisms of regulation. Biofactors 35: 200-208
8. Dhar A, Ray A (2010) The CCN family proteins in carcinogenesis. Exp Oncol 32: 2-9
9. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR (1996) Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107: 404-411 (Pubitemid 26284351)
10. Fuchshofer R, Birke M, Welge-Lussen U, Kook D, Lütjen-Drecoll E (2005) Transforming growth factor-beta 2 modulated extracellular matrix component expression in cultured human optic nerve head astrocytes. Invest Ophthalmol Vis Sci 46: 568-578 (Pubitemid 40270337)
11. Fuchshofer R, Yu AHL, Welge-Lüssen U, Tamm ER (2007) Bone Morphogenetic Protein-7 Is an Antagonist of Transforming Growth Factor-beta2 in Human Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci 48: 715-726 (Pubitemid 351260705)
12. Fuchshofer R, Yu AL, Teng H-H, Strauss R, Kampik A, Welge-Lussen U (2009) Hypoxia/reoxygenation induces CTGF and PAI-1 in cultured human retinal pigment epithelium cells. Exp Eye Res 88: 889-899
13. Gressner OA, Gressner AM (2008) Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 28: 1065-1079
14. Higgins DF, Biju MP, Akai Y, Wutz A, Johnson RS, Haase VH (2004) Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 287: F1223-F1232 (Pubitemid 39507231)
15. Hoek K, Rimm DL, Williams KR, Zhao H, Ariyan S, Lin A, Kluger HM, Berger AJ, Cheng E, Trombetta ES, Wu T, Niinobe M, Yoshikawa K, Hannigan GE, Halaban R (2004) Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 64: 5270-5282 (Pubitemid 39006547)
16. Hsu M-Y, Rovinsky SA, Lai C-Y, Qasem S, Liu X, How J, Engelhardt JF, Murphy GF (2008) Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation. Lab Invest; a Journal of Technical Methods and Pathology 88: 842-855
17. Igarashi A, Okochi H, Bradham DM, Grotendorst GR (1993) Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645 (Pubitemid 23183611)
18. Jacob K, Wach F, Holzapfel U, Hein R, Lengyel E, Buettner R, Bosserhoff AK (1998) In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid. Melanoma Res 8: 211-219 (Pubitemid 28313758)
19. Javelaud D, Alexaki VI, Mauviel A (2008) Transforming growth factor-beta in cutaneous melanoma. Pigment Cell Melanoma Res 21: 123-132 (Pubitemid 351551229)
20. Junglas B, Yu AH, Welge-Lussen U, Tamm ER, Fuchshofer R (2009) Connective tissue growth factor induces extracellular matrix deposition in human trabecular meshwork cells. Exp Eye Res 88: 1065-1075
21. Kanaan RA, Aldwaik M, Al-Hanbali OA (2006) The role of connective tissue growth factor in skeletal growth and development. Med Sci Monit 12: RA277-RA281 (Pubitemid 44916068)
22. Krasagakis K, Kruger-Krasagakes S, Fimmel S, Eberle J, Tholke D, von der Ohe M, Mansmann U, Orfanos CE (1999) Desensitization of melanoma cells to autocrine TGF-beta isoforms. J Cell Physiol 178: 179-187 (Pubitemid 29034861)
23. Krasagakis K, Tholke D, Farthmann B, Eberle J, Mansmann U, Orfanos CE (1998) Elevated plasma levels of transforming growth factor (TGF)-beta1 and TGF-beta2 in patients with disseminated malignant melanoma. Br J Cancer 77: 1492-1494 (Pubitemid 28190751)
24. Kubo M, Kikuchi K, Nashiro K, Kakinuma T, Hayashi N, Nanko H, Tamaki K (1998) Expression of fibrogenic cytokines in desmoplastic malignant melanoma. Br J Dermatol 139: 192-197 (Pubitemid 28389390)
25. Kuphal S, Winklmeier A, Warnecke C, Bosserhoff A-K (2010) Constitutive HIF-1 activity in malignant melanoma. Eur J Cancer 46: 1159-1169
26. Lasfar A, Cohen-Solal KA (2010) Resistance to transforming growth factor beta-mediated tumor suppression in melanoma: are multiple mechanisms in place? Carcinogenesis 31: 1710-1717
27. Maeda A, Nishida T, Aoyama E, Kubota S, Lyons KM, Kuboki T, Takigawa M (2009) CCN family 2/connective tissue growth factor modulates BMP signalling as a signal conductor, which action regulates the proliferation and differentiation of chondrocytes. J Biochem 145: 207-216
28. Medrano EE (2003) Repression of TGF-beta signaling by the oncogenic protein SKI in human melanomas: consequences for proliferation, survival, and metastasis. Oncogene 22: 3123-3129 (Pubitemid 36713764)
29. Nguyen TQ, Goldschmeding R (2008) Bone morphogenetic protein-7 and connective tissue growth factor: novel targets for treatment of renal fibrosiS Pharm Res 25: 2416-2426
30. Piek E, Heldin CH, Ten Dijke P (1999) Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 13: 2105-2124
31. Poser I, Rothhammer T, Dooley S, Weiskirchen R, Bosserhoff AK (2005) Characterization of Sno expression in malignant melanoma. Int J Oncol 26: 1411-1417
32. Rothhammer T, Hahne JC, Florin A, Poser I, Soncin F, Wernert N, Bosserhoff AK (2004) The Ets-1 transcription factor is involved in the development and invasion of malignant melanoma. Cell Mol Life Sci 61: 118-128 (Pubitemid 38121905)
33. Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK (2005) Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res 65: 448-456
34. Rothhammer T, Wild PJ, Meyer S, Bataille F, Pauer A, Klinkhammer-Schalke M, Hein R, Hofstaedter F, Bosserhoff AK (2007) Bone morphogenetic protein 7 (BMP7) expression is a potential novel prognostic marker for recurrence in patients with primary melanoma. Cancer Biomark 3: 111-117 (Pubitemid 47103812)
35. Shimo T, Kubota S, Kondo S, Nakanishi T, Sasaki A, Mese H, Matsumura T, Takigawa M (2001) Connective tissue growth factor as a major angiogenic agent that is induced by hypoxia in a human breast cancer cell line. Cancer Lett 174: 57-64 (Pubitemid 33001308)
36. Van Belle P, Rodeck U, Nuamah I, Halpern AC, Elder DE (1996) Melanoma-associated expression of transforming growth factor-beta isoforms. Am J Pathol 148: 1887-1894
37. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR (2005) Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 65: 8887-8895 (Pubitemid 41377378)
38. Yin D, Chen W, O'Kelly J, Lu D, Ham M, Doan NB, Xie D, Wang C, Vadgama J, Said JW, Black KL, Koeffler HP (2010) Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme. Int J Cancer 127: 2257-2267